Micron’s $100 Billion Order Cushion Meets Its Sternest Test from Washington and Shanghai

The arithmetic of Micron Technology’s current position is brutal in its simplicity. Revenue running at $41.46 billion, gross margins at a record 84.6%, and a $100 billion backlog of strategic customer agreements guaranteeing price floors — yet the stock has shed more than 17% over the past month and sits 32% below its June high. The reason is a one-two punch that no balance sheet can easily parry: a looming US crackdown on high-bandwidth memory exports and a Chinese rival’s $8.5 billion initial public offering.

Washington is weighing tougher unilateral export controls on High Bandwidth Memory (HBM) chips, the key component powering Nvidia’s AI accelerators. Almost simultaneously, ChangXin Memory Technologies (CXMT) announced an IPO to fund a massive domestic production push. The combination has knocked Micron’s shares to €747.00, dragging the RSI down to 40.9 — a level that historically signals an oversold condition, though one that has offered little comfort so far.

The Bull Argument: Structural Scarcity Versus Political Noise

Optimists point to a gap between price action and operational reality that they believe cannot persist. Micron’s entire HBM production for 2026 is already sold under fixed-price contracts, and the company says capacity is effectively booked through 2027. The HBM4 generation is ramping at twice the speed of its predecessor. The analyst consensus price target of €1,297.58 implies a 73.7% upside from current levels.

Beyond AI, the company has been quietly building a second revenue pillar. Recent multi-year contracts with Qualcomm, Visteon, HARMAN, JOYNEXT, DENSO, Astemo, Hyundai Mobis, and General Motors lock in memory supply for connected vehicles — a business with inherently longer product cycles and less volatility than commodity chips. Ground was broken on a new Hiroshima fab in July 2026 to support long-term production.

Year-to-date, the stock still shows a gain of 177.70%, and over twelve months the advance is 665.06%. Bulls argue that the pullback from the June 2026 all-time high is merely a necessary correction after a parabolic rally, and that the 200-day moving average at €422.12 — still far below the current price — keeps the long-term AI narrative intact.

Should investors sell immediately? Or is it worth buying Micron?

The Bear Scenario: Export Risk and a Coming Supply Wave

The bearish counterargument focuses on the vulnerability of that very scarcity thesis. If the US moves from reviewing HBM export restrictions to implementing them, Micron could lose access to a critical revenue stream before its new fabrication plants in New York and Idaho come fully online. The company’s annualized 30-day volatility of 105.98% underscores how sensitive the stock has become to each new regulatory headline.

Then there is the supply side. From 2027 onward, new capacity from multiple manufacturers — including Micron’s own expansions — is expected to hit the market. By 2028 and 2029 the pace of capacity additions could accelerate sharply, potentially normalizing prices and compressing margins. CXMT’s IPO adds another layer of risk: more capital for a direct competitor means more DRAM output, which in a cyclical industry can quickly undermine pricing power.

Technically, the stock has already sliced through its 50-day moving average at €824.57. If buyers do not step in at the psychological support of €700, a test of the 100-day line near €601.17 becomes a real possibility. China’s World AI Conference on July 17 reinforced the government’s push to reduce reliance on Western technology, with Huawei’s Ascend infrastructure positioned as a domestic alternative — potentially bypassing Micron altogether.

The Next Catalyst: August 10 and the Geopolitical Timeline

The competing forces are unlikely to resolve quickly. The make-or-break moment on the near-term calendar is August 10, 2026, when Micron management appears at the KeyBanc Capital Markets Technology Leadership Forum. Investors will be listening for details on HBM4 manufacturing yields, the status of international trade licenses, and any clarity on the scope of potential export restrictions.

A reclamation of the 50-day moving average at €824.57 would signal that the correction has run its course and could open the path back toward €1,000. Failure to hold €700, by contrast, could accelerate the slide toward the 100-day average. In the meantime, the stock is likely to trade sideways between the €700 support and the €850 resistance zone, with the exceptional 106% annualized volatility ensuring that every regulatory whisper and competitor announcement will move the needle.